Solid Dosage

GKF 720 HiProTect Capsule Filler: Maximum Flexibility Meets Potent Containment

With pharmaceutical companies increasing development of highly potent drugs, manufacturers of those drug products, both innovator companies and contract manufacturers alike, continue to seek better contained manufacturing equipment to ensure protection of both personnel and products.

 

While potent drug products come in a variety of dosage forms and potencies, …more


Syntegon to co-host technical forum with Parsolex

Syntegon Pharma Technology is pleased to announce the completion of a major capital investment program with our partners, Parsolex GMP Center. This investment consists of the installation of multiple pieces of equipment to enhance Parsolex’s existing analytical, development and cGMP manufacturing capabilities. The upgraded facility includes …more


Xelum – Excelling in Continuous Manufacturing

Continuous Manufacturing has steadily gained momentum within the Oral Solid Dosage (OSD) industry over the last handful of years. Seeking significantly faster product development, reduced production costs, and higher yields, many pharmaceutical companies have made a concerted effort to implement continuous manufacturing lines within their production facilities. Continuous Manufacturing can allow inefficient batch processing to be a relic of the past, being replaced with smart sensing technology and unsurpassed product quality. …more


Visit Syntegon at the AAPS PharmSci 360 virtual show

Be sure to visit Syntegon at the 2020 AAPS PharmSci 360 virtual show, October 26th – November 5th. We are excited to highlight our solutions for continuous manufacturing, wet granulation, capsule filling, tablet pressing, and more. Our experts will be available to discuss …more



Highly Potent Pharmaceuticals: Syntegon Has Your Containment Solution

In recent decades there has been a significant increase in the number of highly potent active pharmaceutical ingredients (HPAPIs) being developed, with some analysts predicting continued growth of this sector of 10% or more in the coming years. For Oral Solid Dosage (OSD) drug product manufacturers, handling of such potent drugs can present a number of challenges, including …more



Virtual FAT: maximum flexibility in times of crisis

Syntegon’s goal is to make life easier for consumers, patients and customers. This is especially important in times of crisis like the current Corona pandemic. When travel restrictions reduce personal contact to a minimum, other means of communication are required to make sure that time-critical projects do not come to a standstill. Working from home and holding meetings online were obvious alternatives in many business contexts. But what about formats that should be taking place on site? …more


Granulation for the Nutraceutical Market: Improve Your Process Efficiencies and Product Quality

There is no doubt that the current and future outlook for nutraceutical companies manufacturing capsules and tablets will continue to flourish, so how can we present and offer solutions for this burgeoning market? The answer lies in understanding the challenges manufacturers face and the opportunities presented by wet granulation and how effectively this process can be implemented into manufacturing. Globally, …more



Top of page